PuSH - Publication Server of Helmholtz Zentrum München

Immune suppression in renal cell carcinoma.

Semin. Cancer Biol. 17, 330-343 (2007)
DOI PMC
Open Access Green as soon as Postprint is submitted to ZB.
The clear evidence that tumor-infiltrating lymphocytes with anti-tumor activity exist in situ raises the question why renal cell carcinomas (RCCs) progress in vivo. A complex array of factors and pathways has been identified that impinges on innate and adaptive effector cells thereby inhibiting their activity against RCCs. The current picture of suppressive mechanisms that contribute to the failure of the immune system to control RCCs is reviewed here. Understanding these complex host-tumor interactions has broad implications for successful application of cytokine therapy and other forms of immunotherapy for RCC.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
7.378
2.108
33
34
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Renal cell carcinoma; Immune suppression; Tumor escape; Cytokine therapies; Immune therapies
Language english
Publication Year 2007
HGF-reported in Year 2007
ISSN (print) / ISBN 1044-579X
e-ISSN 1096-3650
Quellenangaben Volume: 17, Issue: 4, Pages: 330-343 Article Number: , Supplement: ,
Publisher Saunders
Publishing Place Philadelphia, Pa.
Reviewing status Peer reviewed
POF-Topic(s) 30504 - Mechanisms of Genetic and Environmental Influences on Health and Disease
Research field(s) Immune Response and Infection
PSP Element(s) G-501700-001
Scopus ID 34547653931
PubMed ID 17656104
Erfassungsdatum 2007-06-23